- Home
- VALU vs AMRN Comparison
VALU vs AMRN Comparison
Compare VALU & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALU | AMRN |
|---|---|---|
| Founded | 1931 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 341.6M | 287.9M |
| IPO Year | 1995 | 1998 |
Fundamental Metrics
Financial Performance| Metric | VALU | AMRN |
|---|---|---|
| Price | $43.46 | $12.85 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | 2.2K | ★ 64.9K |
| Earning Date | 12-14-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | 4.55 | ★ 55.00 |
| EPS | ★ 0.50 | N/A |
| Revenue | $36,257,000.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $86.92 | ★ N/A |
| Revenue Growth | 1.08 | ★ 39.22 |
| 52 Week Low | $32.00 | $11.25 |
| 52 Week High | $47.00 | $17.31 |
Technical Indicators
Market Signals| Indicator | VALU | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 62.05 | 60.36 |
| Support Level | $36.25 | N/A |
| Resistance Level | $47.00 | $14.50 |
| Average True Range (ATR) | 1.47 | 0.40 |
| MACD | -0.06 | 0.17 |
| Stochastic Oscillator | 63.17 | 90.63 |
Price Performance
Historical ComparisonAbout VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and makes available copyright data, including a ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets its products under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing, and The Most Trusted Name in Investment Research. Its only operating segment is Publishing.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.